Immunosenescence and vaccine failure in the elderly
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
An age-related decline in immune responses in the elderly results in greater susceptibility to infection and reduced responses to vaccination. This decline in immune function affects both innate and adaptive immune systems. A meeting of experts in immunology and gerontology in Paris, France, in April 2008, considered current understanding of immunosenescence and its clinical consequences. Essential features of immunosenescence include: reduced natural killer cell cytotoxicity on a per cell basis; reduced number and function of dendritic cells in blood; decreased pools of naive T and B cells; and increases in the number of memory and effector T and B cells. In particular, an accumulation of late differentiated effector T cells, commonly associated with cytomegalovirus infection, contributes to a decline in the capacity of the adaptive immune system to respond to novel antigens. Consequently, vaccine responsiveness is compromised in the elderly, especially frail patients. Strategies to address the effects of immunosenescence include ensuring that seroprotective antibody levels against preventable infectious diseases are maintained throughout adulthood, and improving diet and exercise to address the effects of frailty. New vaccines are being developed, such as intradermal and high-dose vaccines for influenza, to improve the efficacy of immunization in the elderly. In the future, the development and use of markers of immunosenescence to identify patients who may have impaired responses to vaccination, as well as the use of end-points other than antibody titers to assess vaccine efficacy, may help to reduce morbidity and mortality due to infections in the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, decreased proliferative activity of T cells after vaccination will reduce vaccine efficacy that is known to be suboptimal in older subjects [6].”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [6]
In the citing paper
“Immunity declines during ageing and this is highlighted by the increased susceptibility to infection induced by previously encountered [1, 2] as well as new emerging pathogens [3-5] and also decreased ability to respond to vaccination [6].”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [6]
In the citing paper
“The efficacy of many vaccines is reduced in older subjects [6]”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [6]
In the citing paper
“On one hand, there is evidence of aging-associated deterioration of the adaptive immune system that affects T-cell and B-cell functions (Gibson et al, 2009;Grubeck-Loebenstein et al, 2009).”
From Microglia Priming with Aging and Stress (2017) · cites this paper as Grubeck-Loebenstein et al, 2009
In the citing paper
“These changes are attributed to aging-associated immune senescence that impairs the ability to fight infections and produce antibodies critical for the efficacy of vaccines (Grubeck-Loebenstein et al, 2009).”
From Microglia Priming with Aging and Stress (2017) · cites this paper as Grubeck-Loebenstein et al, 2009
Citations
Cites
1 retracted
Chandra, R. K. (2002) · Nutrition Research · doi:10.1016/s0271-5317(01)00366-9 · Cited by 26
RetractedFrailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“This progressive proinflammatory state in elderly persons has been called ‘inflamm-aging’ (22).”
BackgroundIPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
Phenotype of frailty: characterization in the women's health and aging studies
Bandeen-Roche, K., Xue, Q.-L., Ferrucci, L., Walston, J., Guralnik, J. M., Chaves, P., Zeger, S. L., & Fried, L. P. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.3.262 · Cited by 1,215 · cited 1×
“In recent years, there has been growing recognition of a ‘frailty phenotype’ in the aging population, which is manifested in unintentional weight loss, exhaustion, weakness, slow walking speed and low physical activity, and is associated with the risk of institutionalization and mortality (59, 60) and of impaired immu…”
BackgroundSteady-state and inflammatory dendritic-cell development
Shortman, K., & Naik, S. H. (2007) · Nature Reviews Immunology · doi:10.1038/nri1996 · Cited by 1,190
Antibody response to influenza vaccination in the elderly: A quantitative review
GOODWIN, K., VIBOUD, C., & SIMONSEN, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.105 · Cited by 1,064
Gavazzi, G., & Krause, K.-H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00437-1 · Cited by 990
Walston, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.20.2333 · Cited by 940
A program to prevent functional decline in physically frail, elderly persons who live at home
Gill, T. M., Baker, D. I., Gottschalk, M., Peduzzi, P. N., Allore, H., & Byers, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020423 · Cited by 871
Cited by
Solana, R., Tarazona, R., Gayoso, I., Lesur, O., Dupuis, G., & Fulop, T. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.04.008 · Cited by 567
Self-citationCalder, P. C., Bosco, N., Bourdet-Sicard, R., Capuron, L., Delzenne, N., Doré, J., Franceschi, C., Lehtinen, M. J., Recker, T., Salvioli, S., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.001 · Cited by 488
Microglia Priming with Aging and Stress
Niraula, A., Sheridan, J. F., & Godbout, J. P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.185 · Cited by 398
Effects of ageing on the immune system: Infants to elderly
Valiathan, R., Ashman, M., & Asthana, D. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12413 · Cited by 380
T Cell Replicative Senescence in Human Aging
P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323
Metadata
- Authors
- Grubeck-Loebenstein, B., Della Bella, S., Iorio, A. M., Michel, J.-P., Pawelec, G., & Solana, R.
- Affiliations
- University of Perugia (IT)
- University Hospital of Geneva (CH)
- University of Tübingen (DE)
- University of Córdoba (ES)
- Venue
- Aging Clinical and Experimental Research
- Published
- 2009-06
- Volume
- 21
- Issue
- 3
- Pages
- 201-209
- ISSN
- 1594-0667 (ISSN-L)
- 1720-8319
- OpenAlex
- W2122455470
- Cited by
- 269
- References
- 89
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 15 · 2023: 2 · 2022: 9 · 2021: 17 · 2020: 13 · 2019: 15 · 2018: 10 · 2017: 20 · 2016: 15 · 2015: 17 · 2014: 14 · 2013: 25 · 2012: 24
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Aging Clinical and Experimental Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi Pasteur
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- immunosenescence, vaccine failure, older adults, frailty, NK cell cytotoxicity, dendritic cells, cytomegalovirus, vaccine response, seroprotection, influenza vaccination, high-dose vaccine, infection susceptibility
- MeSH terms
- Aged, Aging, B-Lymphocytes, Dendritic Cells, Humans, Immune System, Immunity, Innate, T-Lymphocytes, Vaccination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.